FDA Approved: ALDURAZYME — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

The FDA approved a supplemental application for ALDURAZYME (laronidase) from Genzyme to update the product labeling for its use in mucopolysaccharidosis type I.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type

Drugs mentioned

• Aldurazyme (Laronidase)

Snippet

SUPPL AP for ALDURAZYME (LARONIDASE)